DiaMedica Therapeutics Inc.

Historical 13F Holders

Symbol
DMAC
CUSIP
25253X207
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 25253X207 since 12/18/2024, largest first.

Filer % of Class Filed
Trill AB 13G/A
16.9% 2/6/2026
Event 12/31/2025
TomEnterprise AB 13G/A
16.3% 7/30/2025
Event 7/23/2025
Richard Jacinto II 13G/A 9.6% 11/7/2025
Event 9/30/2025
Cooperman Leon G. 13G/A 6.6% 2/17/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Dialectic Capital Management, LP 13G/A
0.3% 2/17/2026
Event 12/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 7 184 k $1.50 M
2026 Q2 89 12.5 M $88.3 M
2026 Q1 103 11.8 M $79.6 M
2025 Q4 95 12.1 M $96.0 M
2025 Q3 82 12.8 M $82.9 M
2025 Q2 60 8.84 M $34.5 M
2025 Q1 61 7.51 M $28.5 M
2024 Q4 49 6.74 M $36.6 M
2024 Q3 44 5.58 M $23.3 M
2024 Q2 36 5.15 M $15.2 M
2024 Q1 37 4.78 M $13.2 M
2023 Q4 43 3.96 M $11.3 M
2023 Q3 41 4.25 M $11.0 M
2023 Q2 37 3.49 M $15.1 M
2023 Q1 28 2.57 M $3.93 M
2022 Q4 32 2.59 M $4.10 M
2022 Q3 27 2.53 M $3.14 M
2022 Q2 32 3.67 M $7.42 M
2022 Q1 38 4.01 M $10.0 M
2021 Q4 46 4.01 M $15.0 M
2021 Q3 39 2.81 M $11.2 M
2021 Q2 48 3.79 M $16.9 M
2021 Q1 42 5.69 M $88.1 M
2020 Q4 37 5.98 M $60.6 M
2020 Q3 34 6.71 M $28.4 M
2020 Q2 24 3.03 M $21.0 M
2020 Q1 23 2.93 M $8.24 M
2019 Q4 17 824 k $4.00 M
2019 Q3 18 957 k $1.98 M
2019 Q2 18 1.28 M $6.37 M
2019 Q1 12 1.01 M $4.60 M
2018 Q4 10 1.03 M $3.00 M